Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Basik

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Surgery|February 1, 1995
Prognosis and recurrence patterns of anal adenocarcinomaM Basik, M A Rodriguez-Bigas, R Penetrante, et al.
The Analyst|May 2, 2018
How iMALDI can improve clinical diagnosticsR Popp, M Basik, A Spatz, et al.
Journal of the National Cancer Institute|November 20, 1996
p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancersM S Kahlenberg, D L Stoler, M Basik, et al.
Genes, Chromosomes & Cancer|January 1, 1997
Genomic instability in sporadic colorectal cancer quantitated by inter-simple sequence repeat PCR analysisM Basik, D L Stoler, K C Kontzoglou, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
The onset and extent of genomic instability in sporadic colorectal tumor progressionD L Stoler, N Chen, M Basik, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2018
Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesiclesS Chennakrishnaiah, B Meehan, E D'Asti, et al.
Gynecologic Oncology Reports|January 22, 2019
Gender differences in how physicians access and process informationR Gotlieb, J Abitbol, J A How, et al.
Oncogene|September 6, 2011
An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancerA Mamo, L Cavallone, S Tuzmen, et al.
Oncogene|November 16, 2010
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexesS Tabariès, Z Dong, M G Annis, et al.
ESMO Open|August 10, 2023
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerG Viale, M Basik, N Niikura, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Surgery|February 1, 1995
Prognosis and recurrence patterns of anal adenocarcinomaM Basik, M A Rodriguez-Bigas, R Penetrante, et al.
The Analyst|May 2, 2018
How iMALDI can improve clinical diagnosticsR Popp, M Basik, A Spatz, et al.
Journal of the National Cancer Institute|November 20, 1996
p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancersM S Kahlenberg, D L Stoler, M Basik, et al.
Genes, Chromosomes & Cancer|January 1, 1997
Genomic instability in sporadic colorectal cancer quantitated by inter-simple sequence repeat PCR analysisM Basik, D L Stoler, K C Kontzoglou, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
The onset and extent of genomic instability in sporadic colorectal tumor progressionD L Stoler, N Chen, M Basik, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2018
Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesiclesS Chennakrishnaiah, B Meehan, E D'Asti, et al.
Gynecologic Oncology Reports|January 22, 2019
Gender differences in how physicians access and process informationR Gotlieb, J Abitbol, J A How, et al.
Oncogene|September 6, 2011
An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancerA Mamo, L Cavallone, S Tuzmen, et al.
Oncogene|November 16, 2010
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexesS Tabariès, Z Dong, M G Annis, et al.
ESMO Open|August 10, 2023
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerG Viale, M Basik, N Niikura, et al.
Pageof 2